What is the brand name for a combination hormonal contraceptive containing levonorgestrel and estradiol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brand Names for Levonorgestrel-Estradiol Combinations

The provided evidence does not contain specific brand name information for levonorgestrel combined with estradiol as a regular contraceptive product currently marketed in the United States.

Key Distinction: Estradiol vs. Ethinyl Estradiol

The combination of levonorgestrel with estradiol (not ethinyl estradiol) has been studied primarily in contraceptive vaginal ring formulations, but these are not currently available as FDA-approved products in the U.S. market 1.

Historical Context

  • Research from the 1980s examined contraceptive vaginal rings releasing levonorgestrel and estradiol (not ethinyl estradiol), with rings releasing approximately 250-290 mcg levonorgestrel and 150-180 mcg estradiol daily 2.
  • These levonorgestrel-estradiol vaginal rings were compared to oral contraceptives but were never brought to market as commercial products 2.

Currently Available Levonorgestrel Combinations

If the question pertains to levonorgestrel combined with ethinyl estradiol (the synthetic estrogen used in modern contraceptives), multiple brand names exist:

  • Oral contraceptives: Various formulations contain 100-150 mcg levonorgestrel with 20-30 mcg ethinyl estradiol 3, 4, 5.
  • Contraceptive patch: A low-dose levonorgestrel and ethinyl estradiol patch has been studied and approved 6.

Clinical Caveat

The specific combination of levonorgestrel with estradiol (rather than ethinyl estradiol) does not have a current brand name product available in the U.S. market 1. If prescribing contraception, clinicians should specify whether they are seeking levonorgestrel with ethinyl estradiol (widely available) or the uncommon levonorgestrel-estradiol formulation (not commercially available).

Related Questions

What is a suitable contraception option for a female patient of reproductive age, considering levonorgestrel-ethinyl estradiol?
What are the typical doses of levonorgestrel (progestin) and ethinyl estradiol (estrogen) in oral contraceptives?
What is a suitable combined oral contraceptive (COC) option for a 16-year-old female?
What is the cause of breakthrough bleeding in an 18-year-old female started on Aviane (ethinyl estradiol and levonorgestrel)?
What labs and initial treatment are recommended for a 31-year-old woman with Nexplanon (etonogestrel implant) experiencing prolonged vaginal bleeding for 3 months?
What are the considerations for using Abilify (aripiprazole) in an 8-year-old pediatric patient?
What is the recommended dose of liposomal amphotericin B (Amphotericin B) for the treatment of neurocryptococcosis in an immunocompromised patient?
What are the guidelines for treating asthma in patients with varying levels of severity and control?
What alternative treatment is recommended for symptomatic E. histolytica infection when paromomycin and diloxanide are unavailable?
What is the best treatment approach for a patient with high cholesterol who is intolerant to statins (HMG-CoA reductase inhibitors)?
What is the next step in managing a 15-year-old patient with a history of Bell's palsy, who was treated with valacyclovir (valacyclovir) and high-dose prednisone (prednisone), showed initial improvement, but experienced worsening symptoms and increased pain after completing treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.